PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11706289

Gender differences in thermoregulation.

H Kaciuba-Uscilko·R Grucza
View original source ↗Export metadata ↓

Abstract

Women differ from men in thermal responses to exogenous heat load and heat loss as well as to endogenous heat load during exercise, because they usually have a larger ratio of body surface to body mass, a greater subcutaneous fat content, and lower exercise capacity. When these differences are eliminated in experimental studies, it appears that women's sweating response to heat load is still smaller than that of men, but they are able to maintain their core body temperature on a similar level to that of men as a result of greater evaporative efficiency of sweating. In addition, the changing rate of sex hormone release during the menstrual cycle modifies thermoregulation in women, so there are differences in resting body temperature and thermal responses to positive or negative heat loads depending on the phase of the cycle. In this review, the changes in thermoregulation in young women taking oral contraceptives and those associated with the menopause and hormonal replacement therapy are also described.

Explore related subjects

Body CompositionBody ConstitutionBody Temperature RegulationContraceptives, OralExerciseFemaleGonadal Steroid HormonesHormone Replacement TherapyHumansMaleMenstrual CycleSex CharacteristicsSweatingJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Kaciuba-Uscilko, R Grucza. 2001. Gender differences in thermoregulation.. https://doi.org/10.1097/00075197-200111000-00012

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Relationship between estrogen use and musculoskeletal function in postmenopausal women.

OBJECTIVES: The purpose of this study was to examine the relationship between estrogen use and muscle strength, bone mineral density (BMD), and body composition variables in postmenopausal women. Forty healthy, untrained women participated in this study. Subjects (53-65 years) were > or =5 years postmenopausal and were categorized into either estrogen replacement therapy (ERT n=20) or non-estrogen replacement therapy (Non-ERT n=20) groups. METHODS: Muscular strength was measured by 1-RM testing using Cybex isotonic weight machines. Handgrip strength was measured using a handgrip dynamometer. Diagnostic Ultrasound was used to determine cross-sectional areas of the biceps brachii and rectus femoris muscle groups. BMD of the lumbar spine, proximal femur, and total body was assessed by Dual Energy X-Ray Absorptiometry (Lunar DPX-IQ). Body composition variables were obtained from the total body scan. Serum osteocalcin was measured as an indicator of bone remodeling. RESULTS: There were no significant differences (P>0.05) for isotonic muscular strength, muscle cross-sectional areas, handgrip strength, or percent fat between ERT and Non-ERT groups. ERT had significantly higher (P<0.05) BMD for the total body, femoral neck and Ward's Area. There were moderate positive relationships between lean body mass and the hip sites (r=0.61-0.70, P<0.05). Regression analyses determined that lean body mass was the strongest predictor of the hip BMD sites. Estrogen use also was a significant predictor for the femoral neck and Ward's Area sites. CONCLUSION: Women taking estrogen exhibited similar muscular strength, muscle size, and body composition as their estrogen-deficient counterparts. Estrogen use was also associated with higher BMD for the total body and hip sites. Generally, body composition, specifically lean body mass, influenced hip BMD more than muscular strength or estrogen use.

Body Composition↗
PubMed2002

The impact of testosterone imbalance on depression and women's health.

Women suffer more often from depression than males, indicating that hormones might be involved in the etiology of this disease. Low as well as high testosterone (T) levels are related to depression and well-being in women, T plasma levels correlate to depression in a parabolic curve: at about 0.4-0.6 ng/ml plasma free T a minimum of depression is detected. Lower levels are related to depression, osteoporosis, declining libido, dyspareunia and an increase in total body fat mass. Androgen levels in women decrease continuously to about 50% before menopause compared to a 20-year-old women. Androgen levels even decline 70% within 24 h when women undergo surgical removal of the ovaries. Conventional oral contraception or HRT cause a decline in androgens because of higher levels of SHBG. Hyperandrogenic states exist, like hirsutism, acne and polycystic ovary syndrome. Social research suggests high androgen levels cause aggressive behavior in men and women and as a consequence may cause depression. Higher androgen values are more pronounced at young ages and before and after delivery of a baby and might be responsible for the "baby blues". It was found that depression in pubertal girls correlated best with an increase in T levels in contrast to the common belief that "environmental factors" during the time of growing up might be responsible for emotional "up and downs". T replacement therapy might be useful in perimenopausal women suffering from hip obesity, also named gynoid obesity. Abdominal obesity in men and women is linked to type 2 diabetes and coronary heart diseases. Testosterone replacement therapy in hypoandrogenic postmenopausal women might not only protect against obesity but also reduce the risk of developing these diseases. Antiandrogenic progestins might be useful for women suffering from hyperandrogenic state in peri- and postmenopause. Individual dosing schemes balancing side effects and beneficial effects are absolutely necessary. Substantial interindividual variability in T plasma values exists, making it difficult to utilize them for diagnostic purposes. Therefore a "four-level-hormone classification scheme" was developed identifying when estradiol (E) and T levels are out of balance. (1) Low E-low T levels are correlated with osteoporosis, depression, and obesity; (2) high E-low T with obesity, decreased libido; (3) high T-low E levels with aggression, depression, increased libido, and substance abuse; (4) high E-high T with type II diabetes risk, breast cancer and cardiovascular risk. Testosterone delivery systems are needed where beneficial and negative effects can be balanced. Any woman diagnosed for osteoporosis should be questioned for symptoms of depression.

Body Composition↗
PubMed2002

Diagnostic approach to the aging male.

Quality of life has become a major issue in health care, particularly in old age. The aging process runs its own course but certain elements potentially lend themselves to intervention. The urologist has excellent opportunities to counsel aging men on general aspects of health and to offer screening for common ailments of old age. It is relevant to distinguish between the process of aging itself and diseases occurring in old age. The latter should be diagnosed and adequately treated. Risk factors for these age-related diseases should be identified and addressed. Several questionnaires have been developed that are helpful. Apart from urological disease, cardiovascular disease, diabetes mellitus and osteoporosis are common conditions. There are now tests available that allow screening. Of great importance is the need to raise awareness in aging men of the possibilities modern medicine offers to improve quality of life, and to encourage these men to utilize them for their benefit.

Body Composition↗